Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 3, 2000

View Archived Issues

Research links autoantibodies to the symptoms of Sjogren's syndrome

New findings on an old drug: metformin

Possible connection between intestinal bacteria and autism revealed

Amiloride fails to show benefit in cystic fibrosis trial

Magainin receives patent for novel obesity compound

New technology may improve safety in testing of adenovirus-based gene therapies

Licensing opportunity from NIH: methods of gene targeting

Adeno-associated virus vector available for licensing from NIH

Licensing opportunity from NIH: AAV4 and its use for gene delivery

NIH offers apoptosis-inducing gene product for licensing

Licensing opportunity from NIH: replication-deficient retroviral vectors

Overexpression of UCP-3 results in reduced tissue mass in mice

Inconclusive results obtained with desferrioxamine in multiple sclerosis trial

Roche seeks approval of Tamiflu in Japan

Bayer's Cipro recommended for approval in treating anthrax exposure

Acadia granted phase I SBIR award for neuropsychiatric research

Concerta approved by FDA, licensed worldwide by Alza

Bavarian Nordic initiates phase I/II trial of metastatic malignant melanoma treatment

New compounds under development at AHP for treatment of inflammatory and autoimmune diseases

JNK protein kinase inhibitors under study at Roche

New selective dopamine D4 receptor antagonists useful for psychosis and schizophrenia

Antibacterial agents under development at British Biotech

New compounds interacting with 5-HT1A receptors useful for depression, etc.

New polypeptides useful for Chlamydia infection

New human lymphocytic membrane proteins under study at Incyte

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...